Risk factors of liver steatosis or non-alcholic steatohepatitis after living liver donor transplantation

被引:0
|
作者
Miyaaki, Hisamistu [1 ]
Miuma, Satoshi [1 ]
Taura, Naota [1 ]
Shibata, Hidetaka [1 ]
Nakao, Kazuhiko [1 ]
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, Nagasaki, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1138
引用
收藏
页码:573A / 574A
页数:2
相关论文
共 50 条
  • [1] Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation
    Miyaaki, Hisamitsu
    Miuma, Satoshi
    Taura, Naota
    Shibata, Hidetaka
    Sasaki, Ryu
    Soyama, Akihiko
    Hidaka, Masaaki
    Takatsuki, Mitsuhisa
    Eguchi, Susumu
    Nakao, Kazuhiko
    [J]. TRANSPLANTATION, 2019, 103 (01) : 109 - 112
  • [2] Liver steatosis after living donor liver transplantation
    Arpornsujaritkun, N.
    Chen, C. -L
    Lin, C. -C
    Wang, C. -C
    Wang, S. -H
    Yong, C. -C
    Lin, T. -L
    Li, W. -F
    Chan, Y. -C
    Yeh, C. -S
    Chiu, K. -W
    Kuo, F. -Y
    Co, J. S. P.
    [J]. TRANSPLANTATION, 2019, 103 (08) : 403 - 403
  • [3] Establishment of non-alcholic steatohepatitis (NASH) model and effect of pioglitazone on the liver
    Kumai, Toshio
    Oonuma, Shigeko
    Takeba, Yuko
    Watanabe, Minoru
    Nakaya, Sachiko
    Tadokoro, Mamoru
    Kobayashi, Shinichi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 88P - 88P
  • [4] The expression of MCP1 and NFκB in the liver of non-alcholic steatohepatitis (NASH) model
    Kumai, Toshio
    Watanabe, Minoru
    Takeba, Yuko
    Matsumoto, Naoki
    Takenoshita, Sachiko
    Harimoto, Toshie
    Koike, Junki
    Kobayashi, Shinichi
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S440 - S440
  • [5] The effect of pioglitazone on the MCP1 expression in the liver of non-alcholic steatohepatitis (NASH) model
    Kumai, Toshio
    Watanabe, Minoru
    Takeba, Yuko
    Oonuma, Shigeko
    Koike, Junki
    Kobayashi, Shinichi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 84P - 84P
  • [6] Risk Factors That Increase Mortality After Living Donor Liver Transplantation
    Yoshizumi, Tomoharu
    Shirabe, Ken
    Taketomi, Akinobu
    Uchiyama, Hideaki
    Harada, Noboru
    Ijichi, Hideki
    Yoshimatsu, Masanori
    Ikegami, Toru
    Soejima, Yuji
    Maehara, Yoshihiko
    [J]. TRANSPLANTATION, 2012, 93 (01) : 93 - 98
  • [7] Epidemiology and risk factors for infection after living donor liver transplantation
    Abad, Cybele Lara
    Lahr, Brian D.
    Razonable, Raymund R.
    [J]. TRANSPLANTATION, 2016, 100 (07) : S409 - S409
  • [8] Epidemiology and risk factors for infection after living donor liver transplantation
    Abad, Cybele Lara R.
    Lahr, Brian D.
    Razonable, Raymund R.
    [J]. LIVER TRANSPLANTATION, 2017, 23 (04) : 465 - 477
  • [9] Risk factors of cytomegalovirus infection after living donor liver transplantation
    Akamatsu, N
    Sugawara, Y
    Kaneko, J
    Kishi, Y
    Makuuchi, M
    [J]. HEPATO-GASTROENTEROLOGY, 2005, 52 (61) : 197 - 199
  • [10] HEPATIC STEATOSIS AFTER PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION.
    Wakayama, Kenji
    Taniguchi, Masahiko
    Shimamura, Tsuyoshi
    Suzuki, Tomomi
    Yamashita, Kenichiro
    Furukawa, Hiroyuki
    Todo, Satoru
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S157 - S157